Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial
Exenatide exerts cognitive effects by modulating the BDNF-TrkB neurotrophic axis in adult mice
The launch of the new brand identity coincides with WeightWatchers announcement today that it is introducing a new, fully integrated experience that unites GLP-1 prescribing, personalized nutrition, behavioral support, coaching, and community within a redesigned app experience and digital platform
Commissioner O of the
It depends on your state: Full practice states (like WA, OR, AZ, NM, IA, MN, WI, MI, MD, DE, RI, CT, VT, NH, ME, AK, HI, DC): Yes, after meeting experience requirements Reduced practice states (NY, IL after 3,600-4,000 hours): Yes, once youve achieved independence Restricted practice states (TX, FL, AL, GA, etc.): No you need a collaborating physician and explicit authority in your practice agreement Even in independent states, ensure you have competency in obesity treatment (consider additional training) and be aware some insurers/pharmacies may request physician involvement for expensive GLP-1 scripts
